Search
for
Sort by
Research 31–60 of 86
- Pathways to inflammation: acne pathophysiology
- Oestrogen functions in skin and skin appendages
- Dermatology of androgen-related disorders
- Ovarian Hypertension: Polycystic Ovary Syndrome
- ACNE
- Increased Androgen Binding Capacity in Sebaceous Glands in Scalp of Male-pattern Baldness
- Sulfatase inhibitors: a patent review
- 5α-Reduced glucocorticoids: a story of natural selection
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- Local and Systemic Reduction by Topical Finasteride or Flutamide of Hamster Flank Organ Size and Enzyme Activity
- Biosynthesis of Dihydrotestosterone by a Pathway that Does Not Require Testosterone as an Intermediate in the SZ95 Sebaceous Gland Cell Line
- Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review
- PLASMA C19 STEROID SULPHATE LEVELS AND INDICES OF ANDROGEN BIOAVAILABILITY IN FEMALE PATTERN ANDROGENIC ALOPECIA
- Steroidogenic Isoenzymes in Human Hair and Their Potential Role in Androgenetic Alopecia
- Novel agents for the treatment of alopecia
- Congenital adrenal hyperplasia
- Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress
- Hormone therapy in acne
- Dehydroepiandrosterone for women in the peri- or postmenopausal phase
- Roles of steroid sulfatase in brain and other tissues
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
- The endocrinology of baldness
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Alopecia - the search for novel agents continues
- Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats
- Persistent Poor Metabolic Profile in Postmenopausal Women With Ovarian Hyperandrogenism After Testosterone Level Normalization
- Adrenal steroid precursors exert potent androgenic action in the hamster sebaceous glands of flank organs and ears.
- 11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro
- Male Pattern Baldness
- Clinical use of 5α-reductase inhibitors